MedTrace Logo

Repetition Prescription Approaches Delivered Via Videoconferencing

NCT04895865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2021-08-13

No results posted yet for this study

Summary

A randomized controlled trial comparing between two approaches of prescribing repetition-numbers in resistance training (RT) sessions on psychological, physiological, and performance outcomes. Sixty healthy and sedentary adults (age range: 18-45) will be randomly allocated to either the "predetermined" or "self-selected" groups. The groups will differ in the amount of choice they will be able to make concerning the resistance of each exercise and the number of repetitions they complete (see detailed description). Both groups will complete two sessions per week composed of body weight and resistance band exercises, lasting 45 minutes for eight weeks. The sessions will be delivered live by a certified instructor using a videoconferencing platform.

The primary aim of this study is:

Compare between the "predetermined" and the "self-selected" repetition prescription approaches on psychological, physiological, and performance outcomes in a cohort of 60 healthy and sedentary adults (age range: 18-45) over an eight-week period of live, videoconferencing RT sessions.

The secondary aim is:

Determine the influence of live, videoconferencing group RT sessions on psychological, physiological, and performance outcomes across groups.

Conditions

  • Health Behavior

Interventions

BEHAVIORAL

RPE-based load and repetition number selection

Providing trainees with choices regarding the load and the number of repetitions to be performed per set and exercise

BEHAVIORAL

Predetermined load and number of repetitions

Trainees predetermine the load and perform ten repetitions per set and exercise

Sponsors & Collaborators

  • Israel Science Foundation

    collaborator OTHER

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Israel Halperin, PhD · Tel Aviv University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-23
Primary Completion
2021-08-10
Completion
2021-08-10

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04895865 on ClinicalTrials.gov